FAINARDI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 9.811
EU - Europa 2.709
AS - Asia 2.116
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
AF - Africa 8
SA - Sud America 3
Totale 14.669
Nazione #
US - Stati Uniti d'America 9.784
CN - Cina 1.056
UA - Ucraina 578
IT - Italia 562
SG - Singapore 561
DE - Germania 399
TR - Turchia 358
GB - Regno Unito 329
PL - Polonia 249
FI - Finlandia 210
SE - Svezia 159
ID - Indonesia 58
BE - Belgio 55
FR - Francia 48
CZ - Repubblica Ceca 31
HK - Hong Kong 30
AT - Austria 26
CA - Canada 26
VN - Vietnam 17
IR - Iran 16
NL - Olanda 10
LT - Lituania 9
AU - Australia 8
RU - Federazione Russa 8
A2 - ???statistics.table.value.countryCode.A2??? 7
EU - Europa 6
RO - Romania 6
IN - India 5
KR - Corea 5
IE - Irlanda 4
MA - Marocco 4
PT - Portogallo 4
BG - Bulgaria 3
BR - Brasile 3
CH - Svizzera 3
ES - Italia 3
IQ - Iraq 3
NG - Nigeria 3
SI - Slovenia 3
HR - Croazia 2
HU - Ungheria 2
JP - Giappone 2
SK - Slovacchia (Repubblica Slovacca) 2
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 14.669
Città #
Woodbridge 1.338
Fairfield 1.093
Chandler 767
Houston 716
Jacksonville 673
Ashburn 612
Santa Clara 578
Ann Arbor 561
Singapore 460
Wilmington 394
Seattle 371
Cambridge 360
Warsaw 239
Izmir 234
Nanjing 219
Ferrara 187
Princeton 180
Beijing 161
Milan 139
Boardman 122
New York 116
Shanghai 110
San Diego 90
Addison 81
Dearborn 80
Helsinki 69
Los Angeles 69
Nanchang 66
Shenyang 63
Bremen 59
Jakarta 57
Brussels 55
Jiaxing 50
Hebei 46
Tianjin 43
Changsha 42
Norwalk 38
Falls Church 32
Hong Kong 30
Brno 29
San Mateo 28
Ningbo 26
Vienna 25
Jinan 24
London 23
Orange 23
Redwood City 23
Auburn Hills 21
Zhengzhou 20
Mountain View 18
Bologna 17
Kunming 17
Toronto 17
Guangzhou 16
Dong Ket 15
Munich 15
Tappahannock 15
Hefei 14
Taizhou 14
Des Moines 13
Falkenstein 13
Rome 13
Verona 13
Washington 13
Leawood 12
Frankfurt am Main 11
Ardabil 10
Kraków 9
Indiana 8
Philadelphia 8
Augusta 7
Hangzhou 7
Kilburn 7
Ottawa 7
Redmond 6
Changchun 5
Lanzhou 5
San Francisco 5
Burnley 4
Clifton 4
Haikou 4
Madison 4
Monmouth Junction 4
Parma 4
Simi Valley 4
Turin 4
Calderara Di Reno 3
Catania 3
Dublin 3
Espoo 3
Ferrara di Monte Baldo 3
Forest City 3
Fuzhou 3
Greifensee 3
Guardialfiera 3
Hounslow 3
Modena 3
Padova 3
Reggio Emilia 3
Sant'elena 3
Totale 11.246
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 346
HLA-G Molecules in Autoimmune Diseases and Infections 165
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 161
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 158
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 150
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 147
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 146
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 143
Emerging topics and new perspectives on HLA-G 140
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 135
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 134
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 134
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 133
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 131
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 130
Cerebrospinal fluid analysis and the determination of oligoclonal bands 130
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 129
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 129
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 128
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 126
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 125
Survival prediction in high-grade gliomas using CT perfusion imaging 124
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 124
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 124
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 123
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 122
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 122
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 121
null 121
Leptin/adiponectin ratio predicts post-stroke neurological outcome 120
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 119
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 119
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 114
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 114
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 113
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 111
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 111
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 111
null 110
null 109
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 106
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 106
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 105
null 104
New insights into HLA-G and inflammatory diseases 103
null 102
Some basic aspects of HLA-G biology. 102
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 102
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 101
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 100
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 100
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 99
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 99
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 99
null 97
null 97
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 97
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 97
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 97
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 96
null 96
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 96
Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. 96
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 95
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 95
Neurofilament ELISA validation 95
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 95
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 94
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 92
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 92
null 90
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 89
null 88
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 88
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 88
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 88
null 87
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 87
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 86
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 86
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 85
Le catene leggere libere liquorale sclerosi multipla 84
null 84
null 84
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 84
null 83
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 81
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 81
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 80
Detection of Parachlamydialike organisms in patients with multiple sclerosis. 79
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 79
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 78
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 77
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 76
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 76
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 76
null 75
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 75
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 72
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci. 72
Totale 10.765
Categoria #
all - tutte 74.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 616
Totale 75.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.545 0 0 0 0 0 345 260 282 207 296 102 53
2020/20211.843 153 131 72 195 78 178 64 221 70 270 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20251.539 103 92 310 158 530 346 0 0 0 0 0 0
Totale 14.959